Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease
Authors
Michael Foley (ORCID: https://orcid.org/0000-0002-0330-5542)
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease
Michael Foley, Rasha Al‐Lamee, Shayna Chotai, Christopher Rajkumar et al.
Citations
12 citations
Journal
Circulation
Topics
Coronary Interventions and Diagnostics
Field-Weighted Citation Impact (FWCI)
6.87
article
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease
Michael Foley, Rasha Al‐Lamee, Shayna Chotai, Christopher Rajkumar, Matthew Shun‐Shin, Ricardo Petraco, Nick Curzen, Gerald Clesham, Rupert Williams, James P. Howard, Frank E. Harrell, Sukhjinder Nijjer, John R. Davies, James Spratt, Thomas R. Keeble, Peter Haworth, Peter O’Kane, Fiyyaz Ahmed‐Jushuf, Graham D. Cole, Tushar Kotecha, Florentina Simader, Dárrel P. Francis, Helen Routledge, Henry Seligman, Jehangir Din, Krzysztof Macierzanka, Manas Sinha, Sayan Sen
article en
12 citations
Abstract
No abstract available for this paper.
Publication Tag
CirculationVol. 151(3)
Institutions
Dorset HealthCare University NHS Foundation Trust (GB), Imperial College Healthcare NHS Trust (GB), St George's, University of London (GB), Royal Free London NHS Foundation Trust (GB), Worcestershire Acute Hospitals NHS Trust (GB), Buckinghamshire Healthcare NHS Trust (GB), University Hospital Southampton NHS Foundation Trust (GB), Portsmouth Hospitals NHS Trust (GB), Lung Institute (US), Essex Cardiothoracic Centre (GB), University of Southampton (GB), Imperial College London (GB), Anglia Ruskin University (GB), Salisbury NHS Foundation Trust (GB), Vanderbilt University Medical Center (US)
Funders
Bristol-Myers Squibb, Pfizer, Philips, AstraZeneca, Boston Scientific Corporation, Amarin Corporation, Haemonetics Corporation, ReCor Medical, National Institute for Health and Care Research, British Heart Foundation, Imperial College London, Servier, Abbott Vascular, Medical Research Council, NIHR Imperial Biomedical Research Centre, Janssen Pharmaceuticals